...
首页> 外文期刊>International Journal of Cardiology >Angiopoietin-1 gene plasmid and bone marrow mononuclear cell transfer accelerates reendothelialization in rat carotid arteries after balloon injury
【24h】

Angiopoietin-1 gene plasmid and bone marrow mononuclear cell transfer accelerates reendothelialization in rat carotid arteries after balloon injury

机译:Angiopoietin-1基因质粒和骨髓单个核细胞转移加速球囊损伤后大鼠颈动脉的内皮再形成

获取原文
获取原文并翻译 | 示例
           

摘要

Re-endothelialization of injured vascular endothelium is effective for prevention of in-stent restenosis as well as stent thrombosis. Vascular-specific growth factors play an important role in the development and formation of vascular networks in humans [1]. Angiopoietin-1 (Ang-1), a vessel-specific growth factor unrelated to VEGF, exerts a specific effect on endothelial cells as well as the maturation and stabilization of blood vessels. Ang-1 does not mediate proliferative activity but rather strongly inhibits apoptosis of endothelial cells [2,3]. Implantation of bone marrow mononuclear cells (BM-MNCs) contributes to neoangiogenesis of ischemic tissues by supplying EPCs into the vasculature and inducing secretion of various angiogenic growth factors [4]. Thus, it can be hypothesized that Ang-1 prevents neointima formation and improves reendothe-lialization, and that a combination treatment utilizing BM-MNCs may produce a beneficial additive effect.
机译:受损血管内皮的重新内皮化可有效预防支架内再狭窄以及支架血栓形成。血管特异性生长因子在人类血管网络的发育和形成中起着重要作用[1]。血管生成素-1(Ang-1)是一种与VEGF不相关的血管特异性生长因子,对内皮细胞以及血管的成熟和稳定具有特殊作用。 Ang-1不介导增殖活性,而是强烈抑制内皮细胞的凋亡[2,3]。骨髓单核细胞(BM-MNCs)的植入通过向血管中供应EPC并诱导各种血管生成生长因子的分泌来促进缺血性组织的新血管生成[4]。因此,可以假设Ang-1阻止了新内膜的形成并改善了内皮的再内皮化,并且利用BM-MNC的联合治疗可以产生有益的累加作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号